Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Other financing activities (2021 - 2025)

Definitive Healthcare's Other financing activities history spans 5 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Other financing activities rose 114.75% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $3.5 million, down 76.07%, while the annual FY2025 figure was $1.7 million, 78.01% down from the prior year.
  • Other financing activities reached $1.1 million in Q3 2025 per DH's latest filing, up from $609000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $7.5 million in Q4 2024 to a low of $126000.0 in Q1 2021.
  • Average Other financing activities over 5 years is $2.0 million, with a median of $1.3 million recorded in 2021.
  • Peak YoY movement for Other financing activities: surged 930.95% in 2022, then tumbled 71.51% in 2023.
  • A 5-year view of Other financing activities shows it stood at $2.1 million in 2021, then skyrocketed by 33.07% to $2.8 million in 2022, then plummeted by 72.24% to $782000.0 in 2023, then skyrocketed by 865.22% to $7.5 million in 2024, then tumbled by 85.92% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Other financing activities are $1.1 million (Q3 2025), $609000.0 (Q2 2025), and $1.9 million (Q1 2025).